This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Hyun Ik Shin: Innovator in Pharmaceutical Chemistry
Introduction
Hyun Ik Shin is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents, Shin has established himself as a key figure in the development of novel compounds and processes.
Latest Patents
Shin's latest patents include an isoxazoline derivative and a novel process for its preparation. This invention relates to an isoxazoline derivative that features a cyclic carboxylic acid hemiketal moiety, which is utilized as a caspase inhibitor. The patent outlines a process for preparing this compound, along with a pharmaceutical composition that incorporates it. Another notable patent is for a process that produces 3-amino-5-fluoro-4-dialkoxypentanoic acid ester. This compound serves as a precursor for 3-amino-5-fluoro-4-oxopentanoic acid, showcasing Shin's expertise in creating valuable chemical intermediates.
Career Highlights
Hyun Ik Shin is currently employed at LG Life Sciences, Limited, where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the advancement of drug development but has also positioned him as a respected inventor in the industry.
Collaborations
Shin collaborates with talented colleagues, including Jae Hoon Lee and Hyeong Wook Choi. These partnerships enhance the research and development efforts within their organization, fostering an environment of creativity and innovation.
Conclusion
Hyun Ik Shin's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His innovative work continues to impact the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile